Five Analysts Cut Lumentum Price Targets; B. Riley Downgrades to Neutral
Needham, Rosenblatt, Susquehanna and TD Cowen kept their ratings while lowering targets.

Key points
- Five firms cut price targets; B. Riley downgraded Lumentum to neutral from buy
- Four firms kept their ratings: Needham and Rosenblatt at buy, Susquehanna positive, TD Cowen hold
- Stock fell 0.6% to $680.16 on Tuesday, after a 37.3% drop over the 20 sessions to Monday
- Marvell agreed to acquire Lumentum in an all-stock deal, per a Monday 8-K filing
Five analysts cut their price targets on Lumentum (Nasdaq: LITE) on Tuesday, and B. Riley Securities downgraded the stock to neutral from buy.
Lumentum agreed on Monday to be acquired by Marvell in an all-stock deal, according to an 8-K filed that day. The rating and target actions came the day after that filing, Lumentum 8-K.
Needham maintained its buy rating and cut its target to $800 from $1,040 before the open. Rosenblatt kept its buy rating and lowered its target to $900 from $1,300 before the open. Susquehanna kept its positive rating and cut its target to $950 from $1,100 before the open. TD Cowen kept its hold rating and lowered its target to $685 from $820 during the session. B. Riley Securities moved to neutral from buy and cut its target to $770 from $1,142 during the session.
Price action
Lumentum closed at $684.40 on Monday, after falling 37.3% over the 20 sessions to that close. On Tuesday the stock fell 0.6% to close at $680.16, while the S&P 500 ETF rose 0.3%.
Where coverage stands
Of the 19 firms that rated the stock in the past year, 15 rated it positive and four rated it neutral before Tuesday, with none negative. The median target among those firms was $1,140, ranging from $526 to $1,400. The five new targets range from $685 to $950.
For scale, Lumentum reported revenue of $3.01 billion for the fiscal year ended June 27, up 83% from a year earlier. It held $2.74 billion in cash and investments as of that date.
Sources
Written with AI from analyst rating changes, SEC filings and market data, and checked against those sources before publishing. Our editorial standards.
More analyst ratings
- Morgan Stanley Downgrades Flagstar Bank to Underweight, Cuts Target to $12 · FLG · Nov. 4, 2026
- BTIG Downgrades Driven Brands to Neutral From Buy · DRVN · Nov. 4, 2026
- Canaccord Genuity Downgrades Resmed to Hold From Buy · RMD · Nov. 2, 2026
- Citigroup Downgrades Arthur J. Gallagher to Neutral, Raises Target to $300 · AJG · Nov. 2, 2026
More on Lumentum
LITE page →
Marvell to Buy Lumentum in $115 Billion Stock Deal; Q3 Revenue Tracks Guidance
Preliminary third-quarter fiscal 2027 revenue was consistent with prior guidance, with the midpoint held and the range narrowed to plus or minus 2%.

Lumentum Beats Estimates With $1.26 Billion Revenue and $4.57 Adjusted EPS
The company forecast fiscal second-quarter revenue of $1.575 billion to $1.625 billion, with non-GAAP diluted EPS of $5.90 to $6.20.